Description

🧬 Overview

Cagrilintide is a synthetic peptide designed to mimic amylin, a hormone co-secreted with insulin that plays a key role in regulating appetite and digestion. Engineered for extended activity, it has become a major focus in metabolic and obesity research, particularly in combination strategies with GLP-1 receptor agonists.

⚙️ Technical Profile

• Compound Name: Cagrilintide
• Type: Long-acting amylin analog
• Structure: Modified peptide with extended half-life
• Molecular Weight: ~3949 g/mol
• Target: Amylin receptors
• Biological Role: Appetite regulation and metabolic modulation
• Purity (Research Grade): Typically ≥98%
• Form: Lyophilized powder / injectable solution (research use)
• Solubility: Water-soluble

⚡ Mechanism of Action

Cagrilintide works by activating amylin receptors, which play a key role in signaling satiety to the brain. This helps reduce appetite and overall caloric intake in research models.

It also slows gastric emptying, contributing to prolonged fullness after meals. Additionally, it influences central nervous system pathways involved in energy balance and feeding behavior.

These combined effects support improved appetite control and metabolic regulation.

🔬 Research Context

Cagrilintide has been extensively studied in obesity and metabolic research, particularly for its ability to reduce food intake and support weight management. It is often explored in combination with GLP-1 receptor agonists like Semaglutide for enhanced metabolic effects.

Research also investigates its impact on long-term weight control, metabolic efficiency, and behavioral aspects of eating. Its extended duration of action makes it a promising candidate in next-generation metabolic therapies.

Ongoing studies continue to evaluate its broader applications in appetite regulation and metabolic optimization.